It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2006.
2006 | Hyderabad, Telangana, India | ActiveTotal Drugs And Intermediates Private Limited, a active private limited company, was established on 02 February 2006 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24222TG2006PTC048986. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 10 professional, Its leadership includes Narasimha Reddy Enukonda (Managing Director), Sunitha Sathi (Director), Alluru Ashokreddy (Director). Past directors included Rambabu Sathi, Anam Mahitha, Anam Hanuman Abhishek Reddy. It holds ₹5.90 Cr open charges and ₹13.78 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at S No 10 Gaddapotharam Jinnaram Mandal, Hyderabad, Telangana, 502319.
U24222TG2006PTC048986
048986
02 February 2006
₹2.00 Cr
₹1.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Total Drugs And Intermediates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narasimha Reddy Enukonda | Managing Director | 01 Jul 2011 | Current |
| Sunitha Sathi | Director | 22 Aug 2022 | Current |
| Alluru Ashokreddy | Director | 01 Jul 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Jan 2021 | Past |
| Pramod Abcsdd | Director | 01 Jul 2011 | Past |
| Pramod Abcsdd | Director | 01 Mar 2012 | Past |
| Pramod Abcsdd | Director | 01 Apr 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Total Drugs And Intermediates Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.07% increase. The company also saw a substantial fall in profitability, with a 34.87% decrease in profit. The company's net worth Soared by an impressive increase of 53.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Total Drugs And Intermediates had a public holding of 18.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹59,000,000.00
₹137,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2024 | State Bank Of India | ₹5.90 Cr | Open |
| 29 Sep 2022 | Others | ₹6.50 Cr | Satisfied |
| 20 May 2020 | Others | ₹5.00 Cr | Satisfied |
| 19 Mar 2012 | Indian Overseas Bank | ₹2.28 Cr | Satisfied |
Explore comprehensive loan charge details -
Total Drugs And Intermediates has a workforce of 10 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Total Drugs And Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Total Drugs And Intermediates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Total Drugs And Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Total Drugs And Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
Progress on A charge registered on 20 May 2020 via Charge ID 100354499 with Others was fully satisfied on 13 Jan 2025. was documented.
The activity A charge with State Bank Of India amounted to Rs. 5.90 Cr with Charge ID 101023674 was registered on 10 Dec 2024. was completed.
The activity A charge registered on 29 Sep 2022 via Charge ID 100620470 with Others was fully satisfied on 05 Jul 2024. was completed.
The activity A charge with Others of Rs. 5.00 Cr registered on 20 May 2020 with Charge ID 100354499 was modified on 02 Jan 2023. was completed.
The CIN of Total Drugs And Intermediates Private Limited is U24222TG2006PTC048986.
Total Drugs And Intermediates Private Limited is headquartered at S No 10 Gaddapotharam Jinnaram Mandal, Hyderabad, Telangana, 502319.
Total Drugs And Intermediates Private Limited was incorporated on 02 February 2006.
The current directors of Total Drugs And Intermediates Private Limited are
The primary industry of Total Drugs And Intermediates Private Limited is Manufacturing.
Total Drugs And Intermediates Private Limited is unlisted.
The authorized capital of Total Drugs And Intermediates Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Total Drugs And Intermediates Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX